Open AccessEvidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy
Author(s) -
Markus Hoffmann,
Anzhalika Sidarovich,
Prerna Arora,
Nadine Krüger,
Inga Nehlmeier,
Amy Kempf,
Luise Graichen,
Martin Sebastian Winkler,
Daniela Niemeyer,
Christine Goffinet,
Christian Drosten,
Sebastian Schulz,
HansMartin Jäck,
Stefan Pöhlmann
Publication year - 2022
Publication title -
mbio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.562
H-Index - 121
eISSN - 2161-2129
pISSN - 2150-7511
DOI - 10.1128/mbio.00364-22
Subject(s) - neutralization , covid-19 , virology , antibody , pandemic , coronavirus infections , immunology , medicine , infectious disease (medical specialty) , disease , outbreak , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom